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Abstract
Objectives: UK Biobank is a landmark cohort of over 500,000 participants which will be used to investigate genetic and non-
genetic risk factors for a wide range of adverse health outcomes. This is the first study to systematically assess the
prevalence and validity of proposed criteria for probable mood disorders within the cohort (major depression and bipolar
disorder).
Methods: This was a descriptive epidemiological study of 172,751 individuals assessed for a lifetime history of mood
disorder in relation to a range of demographic, social, lifestyle, personality and health-related factors. The main outcomes
were prevalence of a probable lifetime (single) episode of major depression, probable recurrent major depressive disorder
(moderate), probable recurrent major depressive disorder (severe), probable bipolar disorder and no history of mood
disorder (comparison group). Outcomes were compared on age, gender, ethnicity, socioeconomic status, educational
attainment, functioning, self-reported health status, current depressive symptoms, neuroticism score, smoking status and
alcohol use.
Results: Prevalence rates for probable single lifetime episode of major depression (6.4%), probable recurrent major
depression (moderate) (12.2%), probable recurrent major depression (severe) (7.2%) and probable bipolar disorder (1.3%)
were comparable to those found in other population studies. The proposed diagnostic criteria have promising validity, with
a gradient in evidence from no mood disorder through major depression and probable bipolar disorder in terms of gender
distribution, socioeconomic status, self-reported health rating, current depressive symptoms and smoking.
Significance: The validity of our proposed criteria for probable major depression and probable bipolar disorder within this
cohort are supported by these cross-sectional analyses. Our findings are likely to prove useful as a framework for a wide
range of future genetic and non-genetic studies.
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Introduction
The UK Biobank cohort was recently launched as a landmark
resource for health-related research which is available to
researchers across the world [1]. It comprises more than
500,000 men and women aged 40–69 years recruited from the
general population in the United Kingdom and who represent a
wide range of exposures typical of the UK population [2]. Baseline
assessments were extensive [2]. Prospective waves of follow-up,
along with linkage to routine National Health Service (NHS)
information will, in due course, allow a comprehensive evaluation
of the contribution of genetics, lifestyle, diet and aspects of the
environment to a wide range of health outcomes, including
diabetes, cardiovascular disease, cancer, dementia and death.
During the last two years of recruitment, questions on depressive
and manic symptoms were added to the assessment protocol
(n = 172,751 participants) [3].
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Relative to other areas of medicine, large-scale population
cohorts that have been assessed in detail with respect to mood
disorder features are scarce, even though the public health and
economic impact of these conditions is considerable [4,5]. The
UK Biobank cohort therefore represents a valuable opportunity to
study the long-term impact of mood disorder symptoms on a wide
range of health and cognitive outcomes. There will also be
opportunities to integrate genetic and environmental data to better
understand risk for mood disorder, as well as comorbidity with
many physical disorders such as obesity and cardiovascular disease
and, longer-term, risk for dementia and premature mortality.
Here we present criteria agreed by our mental health working-
group for classifying a probable lifetime history of mood disorder
(both major depression and bipolar disorder) using the information
collected by UK Biobank on these 172,751 participants. We then
use the baseline data in a descriptive epidemiological study to
compare the demographic, lifestyle and personality characteristics
of participants according to whether they meet the criteria and,
thereby, provide some evidence towards the likely validity of these
criteria.
We anticipate that this work will facilitate future genetic and
non-genetic research on mood disorder within the cohort and
provide a framework for defining mood disorder within large
population cohorts of this kind.
Materials and Methods
UK Biobank invitations and recruitment occurred during 2006–
2010. More than 500,000 men and women aged 40–69 years were
assessed, having been identified from NHS patient registers and as
living within a reasonable travelling distance of an assessment
centre (Figure 1). In the final two years of recruitment 172,751
participants were assessed at baseline with respect to depressive
and manic symptoms. These assessments were part of an extensive
touch-screen questionnaire, more details of which are available on
the UK Biobank website [3].
Defining major depression and bipolar disorder
Questions for assessing a probable history of probable bipolar
disorder were based on the approach for manic symptoms within
the Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I) [6]. These questions were suggested by DJS, NC and JG
and approved by the UK Biobank steering committee (Figure 2)
The questions were: "Have you ever had a period of time lasting at least
two days when you were feeling so good, "high", excited or "hyper" that other
people thought you were not your normal self or you were so "hyper" that you
got into trouble?"; "Have you ever had a period of time lasting at least two days
when you were so irritable that you found yourself shouting at people or starting
fights or arguments?"; "Please try to remember a period when you were in a
"high" or "irritable" state and select which of the following apply: I was more
active than usual, I was more talkative than usual, I needed less sleep than
usual, I was more creative or had more ideas than usual."
Current and previous depressive symptoms were assessed by
items relating to the lifetime experience of minor and major
depression [3], items from the Patient Health Questionnaire
(PHQ) [7] and items on help-seeking for mental health (Figure 3):
"Looking back over your life, have you ever had a time when you were feeling
depressed or down for at least a whole week?"; "Have you ever had a period of
time lasting at least two days when you were so irritable that you found yourself
shouting at people or starting fights or arguments?"; "How many weeks was the
longest period when you were feeling depressed or down?"; "How many periods
have you had when you were feeling depressed or down for at least a whole
week?"; "Have you ever seen a general practitioner (GP) for nerves, anxiety,
tension or depression?"; "Have you ever seen a psychiatrist for nerves, anxiety,
tension or depression?"
Neuroticism, a depression-related personality trait, was assessed
using 12 questions from the Eysenck Personality Inventory
Neuroticism scale (EPIN-R) [3,8]: "Does your mood often go up and
down?"; "Do you ever feel ’just miserable’ for no reason?"; "Are you an
irritable person?’’; "Are your feelings easily hurt?"; "Do you often feel ’fed-
up’?"; "Would you call yourself a nervous person?"; "Are you a worrier?";
"Would you call yourself tense or ’highly strung’?"; "Do you worry too long
after an embarrassing experience?"; "Do you suffer from ’nerves’?"; "Do you
often feel lonely?"; "Are you often troubled by feelings of guilt?"
We convened a series of meetings of Biobank-approved
researchers focusing on mental health and cognition (membership
DJS, JPP, DM, NC, JG, MH, BC, BN, DM, JE, ID and BR) and
after a number of iterations of proposed diagnostic criteria we
agreed the definitions for classifying probable bipolar disorder and
probable major depression, as outlined in Figures 2 and 3
respectively (Unique Data Identifier (UDI) codes listed within
Appendix S1). This included a spectrum of severity from probable
single lifetime episode of major depression, through probable
recurrent major depression (moderate), probable recurrent major
depression (severe) and probable bipolar disorder (types I and II).
In order to identify these clinically meaningful mood disordered
and non-mood disordered groups, we did not include participants
with mild manic symptoms (Figure 2 criteria with less than one
week duration and no treatment/problems) or mild depressive
symptoms (Figure 3 criteria but not assessed by a health
professional). Although as noted above neither depressive nor
manic symptoms were assessed according to a precise diagnostic
schedule, as far as possible we followed the structured diagnostic
approach within the International Classification of Diseases (ICD-
10) [9] and the American Psychiatric Association’s Diagnostic and
Statistical Manual (DSM-IV) [10] (Figure 2 and Figure 3).
Towards the validity of proposed criteria for major
depression and bipolar disorder
To investigate the validity of our proposed definitions of
probable major depression and probable bipolar disorder, we used
available data on social, demographic, lifestyle, personality and
clinical variables from the UK Biobank baseline assessment and
compared across the mood disorder spectrum, from a ‘no mood
disorder’ comparison group, through probable single episode
major depression, probable recurrent major depression (moder-
ate), probable recurrent major depression (severe) and probable
bipolar disorder.
The variables included in these analyses were: gender; ethnicity;
socioeconomic status (neighbourhood-level, assessed using the
Townsend deprivation score where a negative score represents
greater affluence [11]); educational level (age left education and
whether achieved an undergraduate degree); self-reported inability
to work due to sickness; self-assessment of having a long-term
illness; self-assessment of overall health rating; current depressive
symptoms (defined as ‘depressed mood’ and/or ‘unenthusiasm/
uninterest’ (anhedonia) for at least ‘nearly every day in past 2
weeks’); neuroticism score; smoking status and alcohol use.
All descriptive analyses were carried out using the statistical
software Stata [12] and SPSS [13]. In order to examine the
association between probable mood disorder category and
demographic and clinical variables, tests of association were used
which accounted for trend across the categories. An extension of
the Kruskal-Wallis test allowed for the comparison of both
continuous and categorical variables across an ordered categorical
variable (nptrend command in Stata) [14].
Mood Disorders in UK Biobank Cohort
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This study was conducted under generic approval from the
NHS National Research Ethics Service (approval letter dated 17th
June 2011, Ref 11/NW/0382).
Results
Prevalence of a lifetime diagnosis of probable major
depression and bipolar disorder
From the sample of 172,751 participants who were assessed for
depressive and manic symptoms, 149,847 provided sufficient data
to allow an assessment of probable bipolar disorder and/or
probable major depression. From these, 26,847 did not meet our
diagnostic criteria for a mood disorder but were excluded because
of sub-threshold manic or depressive symptoms. The remaining
123,000 participants were coded within mood disordered and non-
mood disordered groups as follows: 7,927 (6.4% satisfied criteria
for a probable single lifetime episode of major depression; 15,013
(12.2%) for probable recurrent major depression (moderate); 8,906
(7.2%) for probable recurrent major depression (severe); 1,615
(1.3%) for probable bipolar disorder (types I and II combined;
bipolar I, n = 808 and bipolar II, n = 807); and 89,539 (72.8%)
participants did not satisfy any of our proposed mood disorder
Figure 1. Invitation and recruitment to UK Biobank.
doi:10.1371/journal.pone.0075362.g001
Figure 2. Proposed criteria for lifetime experience of probable
bipolar disorder (type I and type II).
doi:10.1371/journal.pone.0075362.g002
Figure 3. Proposed criteria for lifetime experience of major
depressive disorder.
doi:10.1371/journal.pone.0075362.g003
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criteria and formed a ‘no mood disorder’ comparison group
(Figure 4).
Information on validity of proposed criteria for probable
major depression and bipolar disorder
Most of the demographic features we assessed provided some
support for the validity of our proposed criteria (Table 1). Given
the large sample sizes, comparisons across groups were statistically
significant (p,0.001) for all variables except ‘age left education’.
However, for certain variables the magnitude of these differences
was small (Table 1).
Gender distribution. The male to female ratio for the
probable bipolar disorder group was approximately equal whereas
there was a predominance of women in the probable recurrent
depression and probable single episode depression groups. For
probable recurrent major depression (moderate) the ratio of
females to males was approximately 7:3.
Ethnicity. There were differences across the mood disorder
groups and the comparison group with respect to ethnicity. The
probable bipolar disorder group had a significantly higher
proportion of non-white individuals, accounted for mostly by a
higher proportion of people who described their ethnicity as either
Asian/Asian British or Black/Black British: 7.4% of the probable
bipolar group compared to 3.3% in the probable recurrent
depression (moderate) group, 2.6% in the probable single episode
depression group, and 6.4% in the no mood disorder comparison
group.
Socioeconomic status. The probable bipolar disorder group
had a significantly higher (more deprived) Townsend score and
there was a gradient from more to less affluent as severity of mood
disorder increased.
Educational level. The four probable mood disordered
groups had a greater proportion of individuals who had achieved
an undergraduate degree (between 35-37% versus 33% in the
non-mood disordered comparison group). Among those who did
not have a degree, the mean age of leaving full-time education was
approximately the same across all groups (16.8 or 16.9 years).
Self-reported functional impairment and ratings of
health. There was a clear gradient in terms of the proportion
of individuals in each group who rated themselves as unable to
work due to sickness. In the probable bipolar disorder group this
figure was 14.2%, versus 11.7% in probable recurrent depression
(severe) group, 4.5% in the probable recurrent depression
(moderate) group, 2.5% in the probable single episode depression
group and 2.0% in the comparison group. Similarly, self-reported
long-term illness levels were highest in the probable bipolar
disorder group (58.5%), lowest in the comparison group (28.2%)
and at intermediate levels in the probable depressive disorder
groups.
This gradient was also a feature in terms of the proportion in
each group who described their overall health rating as poor
(14.1% in the probable bipolar disorder group, 13.8% in the
probable recurrent depression (severe) group, 7.1% in the
probable recurrent depression (moderate) group, 3.7% in the
probable single episode depression group and 3.0% in the no
mood disorder comparison group).
Current depressive symptoms and neuroticism
scores. The proportion of individuals with current depressive
symptoms (defined as depressed mood and/or anhedonia almost
every day for the preceding 2 weeks) was significantly different
across the groups. The probable bipolar disorder group had the
highest levels of current depressive symptoms (12.2%), followed by
the probable recurrent depression (severe) group (9.9%), then the
probable recurrent depression (moderate) group (4.5%), the
probable single episode depression group (1.7%) and the no mood
disorder comparison group (1.5%).
Similarly, mean neuroticism scores were highest in the probable
bipolar disorder and probable severe depression groups (6.57 and
6.82 respectively), lowest in the probable single episode depression
(4.15) and no mood disorder (3.26) groups and at an intermediate
level in the probable moderate recurrent depression group (5.79).
Smoking status and alcohol use. Current smoking rates
were highest in the probable bipolar disorder group at 17.8% and
lowest in the no mood disorder comparison group (5.9%), with a
gradient of higher smoking rates as severity of depression
increased.
No such association was observed for self-reported daily/almost
daily alcohol use, which was similar across all groups at
approximately 20%. However, those within the severe depression
and probable bipolar disorder groups were more likely than the
other groups to report that they did not currently drink alcohol but
Figure 4. Percentage diagnostic breakdown of probable lifetime diagnoses of mood disorder (n=123,000).
doi:10.1371/journal.pone.0075362.g004
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had done previously (62.2% for probable severe depression and
58.9% for probable bipolar disorder, compared to 37.6% in the no
mood disorder comparison group) and when asked for a reason for
stopping alcohol, 34.3% of the probable severe depression group
and 32.3% of the probable bipolar disorder group cited ‘illness or
ill health’ compared to 19.3% in the comparison group.
Discussion
Our goal was to propose a set of criteria for a probable lifetime
history of major depression or bipolar disorder - within the
confines of the assessment questions which were used - and then
provide some evidence towards the likely validity of these criteria.
Overall, the lifetime prevalence rates of probable bipolar disorder,
probable recurrent major depression and probable single episode
major depression were consistent with other population based
lifetime estimates (1.3% for bipolar disorder and 25.8% for major
depression) [15,16]. However, it should be noted that our reliance
on participant self-report of symptoms, and our use of criteria that
are likely to be somewhat less stringent than formal diagnostic
criteria, mean that these estimates of prevalence are for probable
lifetime diagnoses only, rather than actual or confirmed diagnoses.
The majority of the demographic and clinical variables we
compared provided some support for the validity of our proposed
diagnostic criteria. For example, the gender distributions of
approximately 1:1 for probable bipolar disorder and approxi-
mately 2:1 (female:male) for probable recurrent depression are
consistent with a large body of epidemiological research on
lifetime rates of mood disorder in males and females [15,17–21].
As might be expected, self-reported rates of inability to work
due to sickness, of long-term illness and of poor overall health were
highest in the probable bipolar disorder and probable severe
depression groups and lowest in the probable single episode
depression and comparison groups, but perhaps most convincing
in terms of these comparisons were findings with respect to current
depressive symptoms and neuroticism scores. For depressive
symptoms, 12.2% of the probable bipolar disorder group
satisfied our criteria for current depression versus 9.9% for the
probable severe recurrent depression group, 4.5% for the probable
moderate recurrent depression group, 1.7% for the probable single
episode depression group and 1.5% for the no mood disorder
comparison group. This is consistent with several longitudinal
studies of bipolar disorder which have identified that the
experience of clinically significant (although often sub-diagnostic)
depressive symptoms is very common [22–24].
For neuroticism scores, both the probable bipolar disorder and
the probable severe depression groups scored highest (6.57 and
6.82 respectively), the other depression groups were lower, and the
comparison group was lowest. Neuroticism is widely accepted as a
vulnerability marker for a range of mental health problems but
particularly mood disorders [25–30] and there is a recognised
genetic correlation between neuroticism and mood states [31,32].
This finding provides support for the validity of our mood disorder
definitions, even though current low mood may have to some
extent raised scores on the EPI.
For socioeconomic status, there was a gradient from more to less
affluent as severity of mood disorder increased (from no mood
disorder to probable bipolar disorder), in keeping with some
studies linking more deprived social circumstances with risk of
severe mental disorder [33–35]. However, our findings for
ethnicity and educational attainment did not show such a clear
gradient across the groups. Although the probable bipolar disorder
group had a higher proportion of individuals who described their
ethnicity as Asian/Asian British or Black/Black British (7.4%) -
compared to the probable recurrent depression (moderate) group
(3.3%) and the probable single episode depression group (2.6%) -
this figure was close to the figure of 6.4% for the comparison
group. Similarly, the mean age of leaving full-time education and
the percentage of individuals in each group with an undergraduate
degree was broadly similar across mood disorder groups (35-37%
compared to 33.1% for the non-mood disordered comparison
group). It is possible that this finding represents a recall bias, with
better remembering of depressive episodes in those with a stronger
educational background.
Although current smoking rates were highest in the probable
bipolar disorder and probable severe depression groups (17.8%
and 12.8% respectively) and lowest in controls (5.9%), these rates
are somewhat lower than might be expected across all groups,
suggesting a recruitment bias towards non-smokers within the
cohort as a whole. In general, smoking rates in major mental
Table 1. Demographic and clinical characteristics (N = 123,000)
Bipolar disorder
N=1,615
Recurrent major
depression
(severe) N=8,906
Recurrent major
depression
(moderate) N=15,013
Single episode
major depression
N=7,927
No mood disorder
N=89,539
Age Mean (SD) 54.5 (8.08) 55.6 (8.05) 55.4 (7.93) 56.3 (8.01) 57.4 (8.11)
Female N (%) 790 (48.9) 5145 (57.8) 10325 (68.8) 5042 (63.6) 44678 (49.9)
White ethnicity N (%) 1422 (88.8) 8232 (92.8) 14176 (94.7) 7575 (96.0) 81566 (91.5)
Townsend deprivation score Mean (SD) 0.06 (3.31) 20.47 (3.18) 21.08 (2.95) 21.35 (2.77) 21.31 (2.87)
Age left education Mean (SD) 16.9 (2.73) 16.8 (2.70) 16.8 (2.34) 16.9 (2.35) 16.8 (2.46)
Undergraduate degree N (%) 578 (36.0) 3205 (36.2) 5211 (34.9) 2893 (36.7) 29365 (33.1)
Unable to work due to sickness N (%) 228 (14.2) 1038 (11.7) 678 (4.5) 199 (2.5) 1799 (2.0)
Long-term illness N (%) 912 (58.5) 4639 (53.3) 5845 (39.8) 2650 (34.0) 24773 (28.2)
Overall health rating poor N (%) 226 (14.1) 1222 (13.8) 1058 (7.1) 294 (3.7) 2645 (3.0)
Current depressive symptoms N (%) 194 (12.2) 876 (9.9) 675 (4.5) 135 (1.7) 1359 (1.5)
Neuroticism score Mean (SD) 6.57 (3.58) 6.82 (3.39) 5.79 (3.18) 4.15 (3.00) 3.26 (2.91)
Current smoker N (%) 286 (17.8) 1139 (12.8) 1279 (8.5) 621 (7.9) 5256 (5.9)
Daily/almost daily alcohol N (%) 326 (20.2) 1773 (19.9) 2896 (19.3) 1616 (20.4) 18762 (21.0)
doi:10.1371/journal.pone.0075362.t001
Mood Disorders in UK Biobank Cohort
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e75362
illnesses are recognised to be much higher than in the general
population (50–70% compared to 20%–30%) [36].
We did not find a substantial difference between the mood
disordered groups and controls in terms of the proportion
reporting daily or almost daily alcohol use (approximately 20%
across all groups) but more detailed questions about previous
alcohol use suggested that a larger proportion of individuals in the
probable bipolar disorder and probable severe depression groups
had stopped using alcohol for health reasons. This is in keeping
with epidemiological research on the high comorbidity between
severe mood problems such as probable bipolar disorder and
alcohol use disorders. For example, the Epidemiologic Catchment
Area (ECA) study in the United States found that individuals with
bipolar I disorder (BPI) had a lifetime prevalence rate of alcohol
abuse or dependence of 46.2% compared to 16.5% for individuals
with major depressive disorder [37]. Similarly, the National
Comorbidity Survey Replication Study identified a lifetime
comorbidity between bipolar I disorder and alcohol abuse of
56.3% [20].
Strengths and Weaknesses
This is a very large population-based cohort of individuals in
middle age recruited from diverse backgrounds across the UK. We
have attempted to devise and test criteria for a probable lifetime
history of major depression or bipolar disorder which are clinically
meaningful, for example, by specifying minimum duration and
severity criteria, as well as including impairment of functioning
criteria (Figures 2 and 3). It should be noted that the criteria for
depression were based largely only on low mood and anhedonia as
core symptoms and that data on additional depressive symptoms
were not available.
The boundaries of normality, major depression and bipolar
disorder remain a topic of considerable debate and, as such, any
diagnostic criteria for these conditions can only be considered
proposals which will require further clinical validation. Having
said this, we have tried as far as possible to follow a structured
diagnostic approach. It should be noted that in this cross-sectional
analysis we had no external criterion for validity but rather have
used internal social, demographic, lifestyle, personality and clinical
variables.
These data are not suitable for estimating population prevalence
of exposures or outcomes due to the many selection factors that
are likely to be operating. However, the large sample size has
resulted in a widely heterogeneous sample which is appropriate for
etiologic analyses. Our analyses suggest that the criteria used here
for identifying affective disorders are suitable for use in etiological
analyses.
The main disadvantage of these data is the self-report nature of
the assessments and the need for participants to recall past
symptoms and experiences. It is possible that some participants
may have under-reported their experience of mood symptoms,
especially those with more severe depressive disorders [38].
Although the social stigma relating to mental health disorders
such as depression has improved in recent years, stigma remains
an issue for many people and may have contributed to some
under-reporting of depressive or manic features. Another limita-
tion is that we were not able to assess a wider range of factors
which might contribute to some of the differences observed
between groups.
This is a large cohort with considerable detail on a wide range
of demographic, health and cognitive variables. In keeping with
contemporary population cohort studies, the overall recruitment
rate was low at around 5.5%. Participants are unlikely to be
representative of the general population in terms of age, sex,
ethnicity and socioeconomic deprivation and there is likely to have
been recruitment bias in favour of a more motivated and relatively
highly educated group of individuals [39]. Furthermore, our
lifetime estimates of 1.3% for probable bipolar disorder and 25.8%
for probable major depression could be considered high given that
the low participation rate and the likelihood that depression would
be more common among non-participants [40]. Nevertheless, our
prevalence estimates are comparable to those reported in other
population studies.
Conclusions
This analysis of features of major depression and bipolar
disorder within a large sample of the UK Biobank cohort
attempted to quantify the lifetime prevalence of clinically
meaningful mood disorders and provide evidence towards
validation of our proposed diagnostic criteria for probable major
depression and probable bipolar disorder. Our findings provide
initial support for these criteria and will lead on to more detailed
work on the relationship of depressive and manic symptoms to a
range of health outcomes within the cohort. They are also likely to
prove useful as a framework for a wide range of future genetic and
non-genetic studies.
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